Bluejay Diagnostics (BJDX) Accumulated Depreciation & Amortization (2020 - 2026)
Bluejay Diagnostics recorded quarterly Accumulated Depreciation & Amortization of $172380.0 in Q1 2026, up 19.2% quarter-over-quarter from $144617.0 in Q4 2025, and down 19.0% year-over-year from $212826.0 in Q1 2025.
Bluejay Diagnostics' Accumulated Depreciation & Amortization history runs 7 years deep, the most recent figure standing at $172380.0 for Q1 2026.
- In Q1 2026, Accumulated Depreciation & Amortization fell 19.0% year-over-year to $172380.0; the TTM figure through Mar 2026 stood at $172380.0 (down 19.0% YoY), while the FY2025 annual figure was $144617.0, down 25.82% from the prior year.
- Accumulated Depreciation & Amortization came in at $172380.0 for Q1 2026 at Bluejay Diagnostics, up from $144617.0 in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $1.3 million in Q3 2024 to a low of $45000.0 in Q1 2023.
- A 5-year average of $529328.4 and a median of $382795.0 in 2023 frame the typical range for Accumulated Depreciation & Amortization.
- Across the five-year window, Accumulated Depreciation & Amortization jumped 2707.62% in 2024 and slumped 90.81% in 2025, its largest moves.
- Bluejay Diagnostics' Accumulated Depreciation & Amortization stood at $596406.0 in 2022, then tumbled by 35.82% to $382795.0 in 2023, then slumped by 49.07% to $194952.0 in 2024, then retreated by 25.82% to $144617.0 in 2025, then rose by 19.2% to $172380.0 in 2026.
- According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods registered $172380.0, $144617.0, and $119490.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 172,380.00 |
| Mar 31, 2026 | 172,380.00 |
| Dec 31, 2025 | 144,617.00 |
| Dec 31, 2025 | 144,617.00 |
| Sep 30, 2025 | 119,490.00 |
| Sep 30, 2025 | 119,490.00 |
| Jun 30, 2025 | 219,273.00 |
| Jun 30, 2025 | 219,273.00 |
| Mar 31, 2025 | 212,826.00 |
| Mar 31, 2025 | 212,826.00 |
| Dec 31, 2024 | 194,952.00 |
| Dec 31, 2024 | 194,952.00 |
| Sep 30, 2024 | 1.30 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 382,795.00 |
| Dec 31, 2023 | 382,795.00 |
| Sep 30, 2023 | 1.22 Mn |
| Sep 30, 2023 | 1.22 Mn |
| Jun 30, 2023 | 247,000.00 |
| Jun 30, 2023 | 247,000.00 |
| Mar 31, 2023 | 45,000.00 |
| Mar 31, 2023 | 45,000.00 |
| Dec 31, 2022 | 596,406.00 |
| Dec 31, 2022 | 596,406.00 |
| Sep 30, 2022 | 574,753.00 |
| Sep 30, 2022 | 574,753.00 |
| Jun 30, 2022 | 532,629.00 |
| Jun 30, 2022 | 532,629.00 |
| Mar 31, 2022 | 488,808.00 |
| Mar 31, 2022 | 488,808.00 |
| Dec 31, 2021 | 448,837.00 |
| Dec 31, 2021 | 448,837.00 |
| Dec 31, 2020 | 303,118.00 |
| Dec 31, 2020 | 303,118.00 |